BIOCYTOGEN-B News

BIOCYTOGEN-B: ANNOUNCEMENT ACCEPTANCE BY THE SHANGHAI STOCK EXCHANGE OF APPLICATION MATERIALS FOR THE PROPOSED ISSUE OF A SHARES

Jun 20, 2023 05:51 ET

BIOCYTOGEN-B: (1) PROPOSED ISSUE OF A SHARES UNDER SPECIFIC MANDATE AND LISTING ON THE SCI-TECH BOARD AND OTHER ANCILLARY RESOLUTIONS (2) PROPOSED AMENDMENTS TO THE ARTICLES ANCILLARY TO THE PROPOSED ISSUE (3) PROPOSED GUARANTEE FOR A WHOLLY OWNED SUBSIDIA

Mar 30, 2023 04:31 ET

BIOCYTOGEN-B: SUPPLEMENTAL ANNOUNCEMENT IN RELATION TOPROPOSED ISSUE OF A SHARES UNDER SPECIFICMANDATE AND LISTING ON THE SCI-TECH BOARDAND OTHER ANCILLARY RESOLUTIONS

Mar 15, 2023 07:25 ET

BIOCYTOGEN-B: (1) PROPOSED ISSUE OF A SHARES UNDER SPECIFIC MANDATE AND LISTING ON THE SCI-TECH BOARD AND OTHER ANCILLARY RESOLUTIONS AND (2) PROPOSED AMENDMENTS TO THE ARTICLES ANCILLARY TO THE PROPOSED ISSUE

Mar 6, 2023 07:29 ET

BIOCYTOGEN-B: (1) PROPOSED CHANGE OF NON-EXECUTIVE DIRECTOR AND PROPOSED CHANGE OF COMPOSITION OF THE STRATEGY DEVELOPMENT COMMITTEE; (2) PROPOSED CHANGE OF SUPERVISOR; (3) PROPOSED ADOPTION OF THE SHARE AWARD SCHEME

Oct 17, 2022 06:36 ET

BIOCYTOGEN PHARMACEUTICALS: GREEN APPLICATION FORM

Aug 18, 2022 18:29 ET

BIOCYTOGEN-B: GLOBAL OFFERING

Aug 18, 2022 18:23 ET